Search Results - "Rahimi‐Levene, Naomi"

BNT162b2 COVID‐19 vaccine is significantly less effective in patients with hematologic malignancies by Herzog Tzarfati, Katrin, Gutwein, Odit, Apel, Arie, Rahimi‐Levene, Naomi, Sadovnik, Maya, Harel, Lotem, Benveniste‐Levkovitz, Patricia, Bar Chaim, Adina, Koren‐Michowitz, Maya

“…Patients with hematologic malignancies have an increased risk of severe COVID‐19 infection. Vaccination against COVID‐19 is especially important in these…”
Get full text

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine by Maayan, Hannah, Kirgner, Ilya, Gutwein, Odit, Herzog‐Tzarfati, Katrin, Rahimi‐Levene, Naomi, Koren‐Michowitz, Maya, Blickstein, Dorit

“…Background In December 2020 the Israeli Health Ministry began a mass vaccination campaign with the BNT162b2 vaccine. This was an important step in overcoming…”
Get full text

ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 Working Group by Goel, Ruchika, Bloch, Evan M., Pirenne, France, Al‐Riyami, Arwa Z., Crowe, Elizabeth, Dau, Laetitia, Land, Kevin, Townsend, Mary, Jecko, Thachil, Rahimi‐Levene, Naomi, Patidar, Gopal, Josephson, Cassandra D., Arora, Satyam, Vermeulen, Marion, Vrielink, Hans, Montemayor, Celina, Oreh, Adaeze, Hindawi, Salwa, Berg, Karin, Serrano, Katherine, So‐Osman, Cynthia, Wood, Erica, Devine, Dana V., Spitalnik, Steven L.

“…Growing evidence suggests that ABO blood group may play a role in the immunopathogenesis of SARS‐CoV‐2 infection, with group O individuals less likely to test…”
Get full text

E‐learning in transfusion medicine: A scoping review by Al‐Riyami, Arwa Z., Vanden Broeck, Jana, Rahimi‐Levene, Naomi, Das, Soumya, Saxon, Ben, Lin, Yulia, Stanworth, Simon J.

Get full text

The emperor and the blood center by Rahimi‐Levene, Naomi, Levene, Dan, Sandler, S. Gerald

Get full text

Understanding the role of therapeutic plasma exchange in COVID‐19: preliminary guidance and practices by Patidar, Gopal K., Land, Kevin J., Vrielink, Hans, Rahimi‐Levene, Naomi, Dann, Eldad J., Al‐Humaidan, Hind, Spitalnik, Steven L., Dhiman, Yashaswi, So ‐ Osman, Cynthia, Hindawi, Salwa I.

“…Background and objectives Cytokine release syndrome in COVID‐19 is due to a pathological inflammatory response of raised cytokines. Removal of these cytokines…”
Get full text

E-learning in transfusion medicine: An exploratory qualitative assessment by Al-Riyami, Arwa Z, Jensen, Kyle, So-Osman, Cynthia, Saxon, Ben, Rahimi-Levene, Naomi, Das, Soumya, Stanworth, Simon J, Lin, Yulia

“…E-learning programmes are increasingly offered in transfusion medicine (TM) education. The aim of this study was to explore facilitators and barriers to TM…”
Get full text

International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic by Al‐Riyami, Arwa Z., Burnouf, Thierry, Wood, Erica M., Devine, Dana V., Oreh, Adaeze, Apelseth, Torunn Oveland, Goel, Ruchika, Bloch, Evan M., Berg, Karin, Getshen, Mahrukh, Louw, Vernon, Ang, Ai Leen, Lee, Cheuk Kwong, Rahimi‐Levene, Naomi, Stramer, Susan L., Vassallo, Ralph, Schulze, Torsten J., Patidar, Gopal Kumar, Pandey, Hem Chandra, Dubey, Rounak, Badawi, Maha, Hindawi, Salwa, Meshi, Abdullah, Matsushita, Tadashi, Sorrentino, Enrico, Grubovic Rastvorceva, Rada M., Bazin, Renée, Vermeulen, Marion, Nahirniak, Susan, Tsang, Hamilton C., Vrielink, Hans, Triyono, Teguh, Addas‐Carvalho, Marcelo, Hećimović, Ana, Torres, Oscar W., Mutindu, Samclide M., Bengtsson, Jesper, Dominguez, Diego, Sayedahmed, Ahmed, Hanisa Musa, Rozi, Gautam, Bipul, Herczenik, Eszter, So‐Osman, Cynthia

“…Background and Objectives The coronavirus disease 2019 (COVID‐19) pandemic has impacted blood systems worldwide. Challenges included maintaining blood supplies…”
Get full text

Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID‐19 infection by Blickstein, Dorit, Izak, Marina, Filipovich‐Rimon, Talia, Garach‐Jehoshua, Osnat, Rahimi‐Levene, Naomi, Shinar, Eilat, Hamad, Ramzia Abu, Bar‐Chaim, Adina, Koren‐Michowitz, Maya

“…Background and Objectives Passive immunization by the infusion of convalescent plasma (CP) obtained from patients who have recently recovered from COVID‐19,…”
Get full text

Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study by Rahimi‐Levene, Naomi, Chezar, Judith, Yahalom, Vered

“…Background Hemolytic disease of the fetus and newborn (HDFN) is a severe form of anemia caused by maternal antibodies against fetal red blood cells (RBC) that…”
Get full text

Haematological patients' perception of home transfusions: Effect of the COVID‐19 pandemic by Gutwein, Odit, Herzog Tzarfati, Katrin, Apel, Arie, Rahimi‐Levene, Naomi, Michaeli, Hani, Barki‐Harrington, Liza, Koren‐Michowitz, Maya

“…Background and Objectives The COVID‐19 pandemic has led to a growing interest in hospital‐at‐home programmes, including home transfusion services. We studied…”
Get full text

International Forum on the Management of Major Haemorrhage: Summary by Green, Laura, Stanworth, Simon, McQuilten, Zoe, Lin, Victor, Tucker, Harriet, Jackson, Bryon, Badawi, Maha, Hindawi, Salwa, Chaurasia, Rahul, Patidar, Gopal, Pandey, Hem Chandra, Fasola, Foluke, Miyata, Shigeki, Matsumoto, Masanori, Matsushita, Tadashi, Rahimi‐Levene, Naomi, Peer, Victoria, Pavenski, Katerina, Callum, Jeannie, Thompson, Troy, Murphy, Michael, Staves, Julie, Maegele, Marc, Abeyakoon, Chathuri, Rushford, Kylie, Wood, Erica, Nuñez, Maria Antonieta, Mellado, Sandra, Saa, Edgardo, Triyono, Teguh, Pratomo, Bhirowo, Apelseth, Torunn Oveland, Dunbar, Nancy

Get full text

International Forum on Transfusion Education for Healthcare Professionals Who Administer Blood to Patients in Hospitals and Health Services: Summary by Al‐Riyami, Arwa Z., Bielby, Linley, Moss, Rachel, Rahimi‐Levene, Naomi, O'Kane, Aine, Hess, John R., Saba, Noor e, Kim, Kyeong‐Hee, Arora, Satyam, Dua, Seema, Barrett, Claire L., Gonzalez, Carlos A., Ferrari, David Martin, Cini, Paula V., Kumagawa, Midori, O'Reilly, Claire, Thrift, Liz, Wendel, Silvano, Fachini, Roberta, Dias, Lara Faria Souza, Tran, Dung, Steinsvåg, Christine T., Dunbar, Nancy

Get full text

International Forum on Transfusion Education for Healthcare Professionals Who Administer Blood to Patients in Hospitals and Health Services: Responses by Al‐Riyami, Arwa Z., Bielby, Linley, Moss, Rachel, Rahimi‐Levene, Naomi, O'Kane, Aine, Hess, John R., Saba, Noor e, Kim, Kyeong‐Hee, Arora, Satyam, Dua, Seema, Barrett, Claire L., Gonzalez, Carlos A., Ferrari, David Martin, Cini, Paula V., Kumagawa, Midori, O'Reilly, Claire, Thrift, Liz, Wendel, Silvano, Fachini, Roberta, Dias, Lara Faria Souza, Tran, Dung, Steinsvåg, Christine T., Dunbar, Nancy

Get full text

International Forum on the Management of Major Haemorrhage: Responses by Green, Laura, Stanworth, Simon, McQuilten, Zoe, Lin, Victor, Tucker, Harriet, Jackson, Bryon, Badawi, Maha, Hindawi, Salwa, Chaurasia, Rahul, Patidar, Gopal, Pandey, Hem Chandra, Fasola, Foluke, Miyata, Shigeki, Matsumoto, Masanori, Matsushita, Tadashi, Rahimi‐Levene, Naomi, Peer, Victoria, Pavenski, Katerina, Callum, Jeannie, Thompson, Troy, Murphy, Michael, Staves, Julie, Maegele, Marc, Abeyakoon, Chathuri, Rushford, Kylie, Wood, Erica, Nuñez, Maria Antonieta, Mellado, Sandra, Saa, Edgardo, Triyono, Teguh, Pratomo, Bhirowo, Apelseth, Torunn Oveland, Dunbar, Nancy

Get full text

Vox Sanguinis International Forum on transfusion services' response to COVID‐19: Summary by Yazer, Mark H., Jackson, Bryon, Pagano, Monica, Rahimi‐Levene, Naomi, Peer, Victoria, Bueno, José Luis, Jackson, Ryan P., Shan, Hua, Amorim‐Filho, Luiz, Lopes, Maria‐Esther, Boquimpani, Carla, Sprogøe, Ulrik, Topholm Bruun, Mie, Titlestad, Kjell, Rushford, Kylie, Wood, Erica M., McQuilten, Zoe K., Angelis, Vincenzo, Delle Donne, Michela, Murphy, Mike, Staves, Julie, Cho, Duck, Nakamura, Fumihiko, Hangaishi, Akira, Callum, Jeannie, Lin, Yulia, Mogaddam, Mostafa, Gharehbaghian, Ahmad, Lozano, Miquel

Get full text

Early and out‐of‐hospital use of COVID‐19 convalescent plasma: An international assessment of utilization and feasibility by Al‐Riyami, Arwa Z., Estcourt, Lise, Rahimi‐Levene, Naomi, Bloch, Evan M., Goel, Ruchika, Tiberghien, Pierre, Thibert, Jean‐Baptiste, Bruun, Mie Topholm, Devine, Dana V., Gammon, Richard R., Wendel, Silvano, Toungouz Nevessignsky, Michel, Grubovic Rastvorceva, Rada M., Oreh, Adaeze, Romon, Iñigo, Berg, Karin, Kitazawa, Junichi, Patidar, Gopal, So‐Osman, Cynthia, Wood, Erica M.

“…Background and Objectives The use of coronavirus disease 2019 (COVID‐19) convalescent plasma (CCP) in the treatment of patients with severe acute respiratory…”
Get full text

Timing of BNT162b2 vaccine prior to COVID ‐19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study by Gutwein, Odit, Herzog Tzarfati, Katrin, Apel, Arie, Rahimi‐Levene, Naomi, Ilana, Levy, Tadmor, Tamar, Koren‐Michowitz, Maya

“…Abstract The COVID‐19 pandemic continues to pose challenges to the treatment of hemato‐oncology patients. Emergence of COVID‐19 variants, availability of…”
Get full text

Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials by Joffe, Erel, Goldschmidt, Neta, Bairey, Osnat, Fineman, Riva, Ruchlemer, Rosa, Rahimi‐Levene, Naomi, Shvidel, Lev, Greenbaum, Uri, Aviv, Ariel, Tadmor, Tamar, Braester, Andrea, Arad, Ariela, Polliack, Aaron, Herishanu, Yair

“…Objective To evaluate disease characteristics and long‐term outcomes in patients requiring second‐line treatment following fludarabine, cyclophosphamide, and…”
Get full text

A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain by Tadmor, Tamar, Braester, Andrei, Najib, Dally, Aviv, Ariel, Herishanu, Yair, Yuklea, Mona, Shvidel, Lev, Rahimi‐Levene, Naomi, Ruchlemer, Rosa, Arad, Ariela, Fogl, Claudia, Henig, Clara, Barak, Mira, Magal, Lee, Polliack, Aaron, Townsend, Kelly

“…Background Chronic lymphocytic leukemia (CLL) is frequently accompanied by immune dysregulation. Aims In this multicenter prospective study, we investigated…”
Get full text